Nxera sells APAC license to lupus drug to Viatris for $10M upfront

Nxera Pharma has sold the Asia-Pacific rights to its phase 3 autoimmune drug to Viatris for $10 million upfront.

Feb 28, 2025 - 11:42
 0
Nxera sells APAC license to lupus drug to Viatris for $10M upfront
Nxera Pharma has sold the Asia-Pacific rights to its phase 3 autoimmune drug to Viatris for $10 million upfront.